pyrroles has been researched along with Corneal Angiogenesis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt, G; Cakmak, H; Ergin, K; Gokmen, E; Kocaturk, T | 1 |
| Blacher, S; Cataldo, D; Detry, B; Erpicum, C; Foidart, JM; Lambert, V; Maertens, L; Maillard, C; Munaut, C; Noël, A; Paupert, J; Rakic, JM; Sounni, NE | 1 |
| Goktas, S; Ivacik, IS; Ozcimen, M; Sakarya, R; Sakarya, Y | 1 |
| Ko, BY | 1 |
| Campos-Mollo, E; Cuenca-Navarro, N; Fernández-Sánchez, L; Lledó-Riquelme, M; Pérez-Santonja, JJ | 1 |
| Bozkurt, G; Çakmak, H; Ergin, K; Evliçoğlu, GE; Kocatürk, T | 1 |
| Kim, JH; Lee, JY; Lee, KJ; Lee, SM; Ryu, W; Seo, IH; Song, HB | 1 |
| Ishimori, A; Sakimoto, T | 1 |
| Alió, JL; Campos-Mollo, E; Javaloy, J; Lledó-Riquelme, M; Pérez-Santonja, JJ | 1 |
| Aydın, B; Erdurmuş, M; Karadağ, R; Keskin, U; Totan, Y | 1 |
| Hollyfield, JG; Hong, L; Salomon, RG | 1 |
| Baek, SG; Jean, WS; Kang, J; Kim, JM; Kim, YS; Ko, BY; Lee, GW; Lee, NS | 1 |
1 review(s) available for pyrroles and Corneal Angiogenesis
| Article | Year |
|---|---|
Discovery of carboxyethylpyrroles (CEPs): critical insights into AMD, autism, cancer, and wound healing from basic research on the chemistry of oxidized phospholipids.
Topics: Animals; Antibodies; Autistic Disorder; CD36 Antigens; Cornea; Corneal Neovascularization; Endothelial Cells; Humans; Macular Degeneration; Mice; Mice, Knockout; Neoplasms; Oxidation-Reduction; Phospholipids; Protein Processing, Post-Translational; Pyrroles; Retinal Rod Photoreceptor Cells; Toll-Like Receptor 2; Wound Healing | 2011 |
11 other study(ies) available for pyrroles and Corneal Angiogenesis
| Article | Year |
|---|---|
Effects of sunitinib and bevacizumab on VEGF and miRNA levels on corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Cornea; Corneal Neovascularization; Indoles; Male; MicroRNAs; Pyrroles; Rats; Silver Nitrate; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Corneal Neovascularization; Disease Models, Animal; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Glycoproteins; Indoles; Lymphangiogenesis; Lymphatic Vessels; Macrophages, Peritoneal; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Placenta Growth Factor; Platelet Endothelial Cell Adhesion Molecule-1; Pregnancy Proteins; Protein-Tyrosine Kinases; Pyrroles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Corneal Neovascularization; Disease Models, Animal; Female; Indoles; Pyrroles | 2013 |
Reply: To PMID 23377751.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Corneal Neovascularization; Disease Models, Animal; Female; Indoles; Pyrroles | 2013 |
[Vascular morphological and microdensity changes of corneal neovascularization induced by topical bevacizumab and sunitinib in an animal model].
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Arteries; Bevacizumab; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Indoles; Male; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyrroles; Rabbits; Sunitinib; Sutures; Vascular Endothelial Growth Factor A; Veins | 2013 |
The effects of topical everolimus and sunitinib on corneal neovascularization.
Topics: Actins; Administration, Topical; Angiogenesis Inhibitors; Animals; Cornea; Corneal Neovascularization; Drug Therapy, Combination; Everolimus; Indoles; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pyrroles; Rats; Sunitinib; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery.
Topics: Administration, Ophthalmic; Animals; Corneal Neovascularization; Drug Delivery Systems; Human Umbilical Vein Endothelial Cells; Indoles; Mice, Inbred C57BL; Microinjections; Needles; Neovascularization, Physiologic; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor A | 2015 |
Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation.
Topics: Administration, Topical; Animals; Cells, Cultured; Cornea; Corneal Neovascularization; Disease Models, Animal; Janus Kinase 3; Keratitis; Male; Mice; Mice, Inbred BALB C; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles | 2016 |
Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Corneal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Indoles; Male; Ophthalmic Solutions; Platelet-Derived Growth Factor; Pyrroles; Rabbits; Random Allocation; Sunitinib; Vascular Endothelial Growth Factor A | 2010 |
Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Cautery; Corneal Neovascularization; Disease Models, Animal; Indoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Pyrroles; Silver Nitrate; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Female; Immunoenzyme Techniques; Indoles; Platelet Endothelial Cell Adhesion Molecule-1; Pyrroles; Rabbits; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |